sodium lactate compound infusion 1litre viaflo bags
baxter healthcare ltd - sodium chloride; potassium chloride; calcium chloride; sodium lactate - infusion - 6mg/1ml ; 400microgram/1ml ; 270microgram/1ml ; 3.17mg/1ml
plasma-lyte 148 (ph 7.4) solution for infusion n/a
baxter healthcare limited - sodium chloride; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate; sodium gluconate - solution for infusion - sodium chloride 5.26 g/l; potassium chloride 0.37 g/l; magnesium chloride hexahydrate 0.30 g/l; sodium acetate trihydrate 3.68 g/l; sodium gluconate 5.02 g/l - blood substitutes and perfusion solutions
plasma-lyte 148 (ph 7.4) solution for infusion n/a
baxter healthcare limited - sodium chloride; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate; sodium gluconate - solution for infusion - sodium chloride 5.26 g/l; potassium chloride 0.37 g/l; magnesium chloride hexahydrate 0.30 g/l; sodium acetate trihydrate 3.68 g/l; sodium gluconate 5.02 g/l - blood substitutes and perfusion solutions
baxter compound sodium lactate solution and 5% glucose 1000ml injection ahb2074
baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 6 g/l; sodium lactate, quantity: 3.22 g/l; potassium chloride, quantity: 400 mg/l; calcium chloride dihydrate, quantity: 270 mg/l - injection, solution - excipient ingredients: water for injections - compound sodium lactate solution and 5% glucose is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are compatible with the solutions.
baxter compound sodium lactate solution and 5% glucose 500ml injection ahb2073
baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 6 g/l; sodium lactate, quantity: 3.22 g/l; potassium chloride, quantity: 400 mg/l; calcium chloride dihydrate, quantity: 270 mg/l - injection, solution - excipient ingredients: water for injections - compound sodium lactate solution and 5% glucose is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are compatible with the solutions.
plasma-lyte 148 (ph 7.4) solution for infusion (500ml)
baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - sodium chloride, potassium chloride, magnesium chloride, hexahydrate, sodium acetate, trihydrate, sodium gluconate - solution for infusion - sodium chloride 5.26 g/l potassium chloride 0.37 g/l magnesium chloride hexahydrate 0.30 g/l sodium acetate trihydrate 3.68 g/l sodium gluconate 5.02 g/l - blood substitutes and perfusion solutions
ephedrine adult nasal drops
ephedrine hcl - nasal drops - ephedrine hcl b.p 1.0 w/v - ephedrine combinations
argotone nasal drops
rona laboratories limited - ephedrine mild silver protein sodium chloride -
argotone spray
rona laboratories limited - ephedrine mild silver protein sodium chloride -
neosynephrine 1% phenylephrine hydrochloride 10mg/1ml injection usp ampoule
pfizer australia pty ltd - phenylephrine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; sodium citrate dihydrate; sodium metabisulfite; nitrogen; sodium chloride; citric acid - indications as at 01 jan 1991 : phenylephrine hydrochloride is intended for the maintenance of an adequate level of blood pressure during spinal and inhalation anesthesia and for the treatment of vascular failure in shock, shock-like states, and drug-induced hypotension, of hypersensitivity. it is also employed to overcome paroxysmal supraventricular tachycardia, to prolong spinal anesthesia, and as a vasoconstrictor in regional analgesia.